Health Care/Hospital
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies
Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience to receive upfront and milestone payments up to $430 million, plus royalties, from Endeavor BioMedicines Investigational New Drug ...
NUS scientists develop innovative magnetic gel that heals diabetic wounds three times faster
First-of-its-kind cell therapy promotes wound healing, improves overall wound health and lowers risks of recurrence SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-h...
World's first expo on health and healing! 2023 Sancheong World Traditional Medicine Anti-aging Expo ends with great success
- The world's first festival on health and healing, featuring a variety of content - Opportunity to enhance the competitiveness of K-anti-aging industry and show the excellence of traditional Korean medicine to the world GYEONGNAM, South Korea, Oct. 19, 2023 /PRNewswire/ -- The 2023 Sancheong W...
Phase 1a/1b Study Results of Akeso's PD-1/CTLA-4 Bispecific Antibody Published in Cell Reports Medicine, Highlighting Promising Efficacy in Solid Tumors Refractory/Relapsed to Standard Therapy
HONG KONG, Oct. 19, 2023 /PRNewswire/ -- Akeso (9926. HK) announced the publication of the phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab (PD-1/CTLA-4 bispecific antibody) in patients with advanced solid tumors in Cell Reports Medicine, a sub-publication of Cell. Full ar...
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
JINAN, China, Oct. 19, 2023 /PRNewswire/ -- Data from Qilu Pharmaceutical's clinical trial of its novel bifunctional antibody, QL1706 (iparomlimab and tuvonralimab), will be unveiled during a mini oral presentation at the European Society for Medical Oncology (ESMO) Annual Congress 2023. The ESMO...
PureSoftware Appoints Industry Veteran Steve Rosenberg as Board Advisor to Strengthen its Life Sciences and Healthcare Vertical
NEW YORK and NOIDA, India, Oct. 19, 2023 /PRNewswire/ -- PureSoftware, a global software and services provider, is proud to announce the appointment ofSteve Rosenberg, a distinguished leader in the Life Sciences and Healthcare technology industry, to its Advisory Board. With a career spanning ove...
InxMed Presents New Data at 14th Annual World ADC Highlighting Synergy of IN10018 with ADCs and Novel Stroma targeting pipeline
NANJING, China, Oct. 18, 2023 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome treatment resistance for hard-to-treat solid tumors, is presenting preclinical data at 14th Annual World ADC Conference in San Diego regar...
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability
* The study has achieved its primary objectives, confirming the safety and tolerability profile of TLX591 administered in two doses, two weeks apart in combination with standard of care (SoC) * Preliminary activity demonstrates meaningful PSA[1] reduction; monitoring of patients is ongoing, i...
Zepp Health Sponsors Cal Hacks 10.0, the World's Largest Collegiate Hackathon, for the Second Consecutive Year
- Winners with the best apps will receive Zepp's Amazfit smartwatches and cash award MILPITAS, Calif., Oct. 18, 2023 /PRNewswire/ -- Zepp Health Corporation, a global leader in smart wearables and health technology, is excited to announce its sponsorship of Cal Hacks, the world's largest collegi...
ITRI Excels with Eight 2023 R&D 100 Awards, Showcasing Biotechnological Triumph
HSINCHU, Oct. 18, 2023 /PRNewswire/ -- In the recent announcement of the 2023
R&D 100 Awards,ITRI
Dr. Huda Zoghbi Reveals New Research Into the Mechanisms Driving Rett Syndrome at the 2023 World Congress of Neurology
MONTREAL, Oct. 19, 2023 /PRNewswire/ -- Huda Zoghbi, MD, professor of molecular and human genetics,Baylor College of Medicine, has made a groundbreaking discovery in the field of neurology. Her research shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood ...
Frost & Sullivan Recognizes Neuromod Devices with the 2023 New Product Innovation Award for Developing a Robust Solution That Meets Tinnitus Patients' Needs
Neuromod Devices uniquely leverages its sophisticated technology to meet tinnitus patients' dynamic needs and strict global regulatory requirements for medical devices. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the neuromodulation devices for tinnitus space ...
Driving Innovation in Diagnostics: Fapon's Latest Solutions at Indonesia Hospital Expo 2023
JAKARTA, Indonesia, Oct. 18, 2023 /PRNewswire/ -- Fapon, a leading life-science company, will showcase its latest innovations in IVD core raw materials, reagent services and open instrument platforms at Indonesia Hospital Expo 2023 fromOctober 18 to October 21, 2023. During the exhibition, the co...
CJ Foods Partners with T&R Biofab to Shape the Future of Food
CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agre...
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study
BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compare...
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
GAITHERSBURG, Md., Oct. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced thatSingapore's Health Sciences Authority (HSA) has granted full approval for Novavax's prototype COVID-19 vaccine Nuvaxovi...
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland, Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in da...
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
* With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry * Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities * Shortlisted as a finalist for ...
Complete Genomics Partners with Integrated DNA Technologies to Establish New Ecosystem of NGS Products
SAN JOSE, California, Oct. 18, 2023 /PRNewswire/ -- Complete Genomics, Inc., a
pioneering genomic sequencing company, today announced its partnership with
Integrated DNA Technologies (IDT),
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39